Literature DB >> 8463618

Metastatic prostate cancer simulating sclerosing cholangitis.

J Taylor1, K Lindor.   

Abstract

We report what we believe to be the first case of metastatic prostate cancer presenting as sclerosing cholangitis. In a 71-year-old man with known prostate cancer and cholestatic jaundice, an endoscopic retrograde cholangiopancreatography revealed multifocal strictures of both the intrahepatic and extrahepatic biliary system consistent with sclerosing cholangitis. Review of a liver biopsy and cholecystectomy specimen showed metastases from prostate cancer, which stained positively with prostate-specific antigen. Multiple hepatic metastases from prostate cancer should be included among the conditions that simulate primary sclerosing cholangitis on cholangiography.

Entities:  

Mesh:

Year:  1993        PMID: 8463618     DOI: 10.1097/00004836-199303000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Docetaxel Induced Sclerosing Cholangitis.

Authors:  Jennifer L Horsley-Silva; Elizabeth N Dow; Christine O Menias; Maxwell L Smith; Estrella M Carballido; Keith D Lindor; Hugo E Vargas
Journal:  Dig Dis Sci       Date:  2015-12       Impact factor: 3.199

2.  Secondary Sclerosing Cholangitis due to Gallbladder Adenocarcinoma.

Authors:  David Sicong Fan; Serge Alexander Sorser; Roberto Mauro Gamarra
Journal:  Case Rep Gastroenterol       Date:  2013-03-13

3.  Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma.

Authors:  Muhammad A Kabeer; Edward Lloyd-Davies; Giles Maskell; Rolf Hohle; Joseph Mathew
Journal:  World J Surg Oncol       Date:  2007-01-07       Impact factor: 2.754

4.  Resolution of Diffuse Intrahepatic Biliary Strictures after Chemotherapy for Metastatic Ovarian Cancer.

Authors:  Daniel Lew; Vinay Sundaram; Brad D Barrows; Simon K Lo; Srinivas Gaddam
Journal:  ACG Case Rep J       Date:  2017-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.